Pharmafile Logo
Pharmafocus logo
Advanced Search
A example of a myelinated neuron

Old antibiotic offers potential cost-effective MS treatment

June 2, 2017
Medical Communications, Research and Development Myelin, multiple sclerosis

The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …

News

NICE U-turns to recommend Sanofi Gaucher disease drug

June 2, 2017
Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi

It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …

News
india_child_doctor

Childhood mortality from diarrhoea falls by third

June 2, 2017
Medical Communications Diarhhoea, India, Nigeria

A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …

News

Clinical Trial Success: How Relationships Are Key

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …

Feature
White paper
hoffman

Silence Therapeutics instate new COO

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …

Appointment

Europe vs USA: New drug approvals

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …

Feature
White paper
640px-palace_of_westminster_at_night

What the life sciences industry wants from the next UK government

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …

Feature
3117187373_19549d5407_z

New method discovered to target chronic pain

June 1, 2017
Research and Development opioid, painkillers

Chronic pain is notoriously difficult to treat and can lead some people to take painkillers of increasing strength to combat …

News
1280px-epi-pen_1

Mylan overcharged for EpiPen by $1.7 billion, new report says

June 1, 2017
Sales and Marketing Mylan, epipen

More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the …

News
european_commission_web

New biosimilar guidelines launched in the EU

June 1, 2017
Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars

A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …

News
pills_in_hand

Ohio takes legal action against pharma companies for opioid crisis

June 1, 2017
Medical Communications Ohio, opioid, opioid crisis

If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …

News

Navigating the challenges of health technology assessment

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …

Feature
Case study
student_writing

NLS Pharma reveals data on different kind of ADHD treatment

May 31, 2017
Research and Development NLS Pharma, mazindol

Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …

News
joe-ciaffoni-biogen-750xx2574-1445-0-143

Collegium bring in former Biogen SVP as new COO

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …

Appointment
shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

Feature
fdaoutsideweb

FDA approves first generic versions of Lilly’s ADHD drug

May 31, 2017
Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …

News
valium_10mg_roche

Evidence of tampering with Valium medication in Australia

May 31, 2017
Medical Communications, Research and Development Roche, valium

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …

News
novartis_window

Mounting US pricing pressures cutting into quarterly sales, Novartis admits

May 31, 2017
Research and Development, Sales and Marketing Novartis, Sandoz

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …

News
220399586_ec18abd879_z

MSD allays Irish fears with €280m expansion investment

May 31, 2017
Manufacturing and Production, Research and Development Ireland, MSD

There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026